Janux Therapeutics, Inc. (JANX)
13.84
-0.13
(-0.93%)
USD |
NASDAQ |
Mar 06, 16:00
14.00
+0.16
(+1.16%)
After-Hours: 20:00
Janux Therapeutics SG&A Expense (TTM) : 41.77M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Bristol Myers Squibb Co. | 7.267B |
| MannKind Corp. | 229.86M |
| EyePoint Plc | 40.32M |
| Madrigal Pharmaceuticals, Inc. | 813.83M |
| CorMedix, Inc. | 60.19M |